Regulatory Updates

Latest News

FDA Approves Drop for Drug-Induced Dilation of the Pupils
FDA Approves Drop for Drug-Induced Dilation of the Pupils

September 27th 2023

Ryzumi is expected to be available in the first half of 2024. Pricing will be available around the time of launch.

FDA Assigns Review Date for Dupixent in Young Children with Eosinophilic Esophagitis
FDA Assigns Review Date for Dupixent in Young Children with Eosinophilic Esophagitis

September 26th 2023

FDA Issues Complete Response for Udenyca OnBody
FDA Issues Complete Response for Udenyca OnBody

September 25th 2023

FDA Approves Jardiance for Patients with Chronic Kidney Disease
FDA Approves Jardiance for Patients with Chronic Kidney Disease

September 22nd 2023

Drugs to Watch: Cancer
Drugs to Watch: Cancer

September 22nd 2023

More News

© 2023 MJH Life Sciences

All rights reserved.